Diabetic Foot Ulcer Treatment Market

Diabetic Foot Ulcer Treatment Market by Type (Ischemic Ulcers, Neuro-Ischemic Ulcers, Neuropathic Ulcers), by Treatment Type (Active Therapies, Wound Care Dressings, Therapy Devices, Others), and End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Centers, Others) – Global Outlook & Forecast 2022-2030

GR - 650966 Category: Medical Devices

Number of pages: 100 | Report Format: PDF | Published date: 03 October, 2022

Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030

Report Overview

The global diabetic foot ulcer treatment market was pegged at US$ 3.54 billion in 2021 and is expected to witness a CAGR of 5.7% during the forecast period from 2022 to 2030.

Market Fundamentals

A diabetic foot ulcer is a common complication caused by diabetes mellitus. It is a skin sore wherein the skin tissue breaks down and can infect the surrounding tissue or even the bone. This kind of disease is growing rapidly due to the increasing number of diabetes patients, thus, greatly influencing the diabetic foot ulcer treatment market.

[7868534]

Market Dynamics

The global diabetic foot ulcer treatment market is an emerging industry and is expected to depict constant growth in the projected period. This growth can be attributed to the increasing prevalence of diabetes mellitus, which proportionately impacts the growth of diabetic foot ulcer conditions as complications of diabetes. Additionally, growing urbanization is also a significant cause for the rise in the obese population, poor health, lack of physical activities, and lack of proper diet among the population. Furthermore, technological advancements and increasing awareness about foot ulcer treatments further fuel the market expansion. However, the high cost of the diabetic foot ulcers treatment can prove to be major restraining factor in the market.

Market Ecosystem

The global diabetic foot ulcer treatment market has been analyzed from four perspectives: by type, treatment type, end-user, and region.

Diabetic Foot Ulcer Treatment Market by Type

Based on type, the global diabetic foot ulcer treatment market is segmented into ischemic ulcers, neuro-ischemic ulcers, and neuropathic ulcers. Neuro-ischemic ulcers hold the largest revenue share in the segment owing to a high prevalence of neuro-ischemic ulcers, thus, growth in the treatments. Furthermore, this type of foot ulcer has a considerable concern about infection, amputation, and could lead to fatality. While neuropathic ulcer holds the second largest revenue share with the growing cases of neuropathic diabetic foot ulcers.

Diabetic Foot Ulcer Treatment Market by Treatment Type

[65443243]

Based on the treatment type, the global diabetic foot ulcer treatment market is segmented into active therapies, wound care dressings, therapy devices, and others (photodynamic therapy, photo biomodulation, etc.). Wound care dressings dominate the market with the largest share in the segment. The growth of wound care dressings segment is attributed to high R&D activities and the continuous launch of new and innovative dressing products.

While therapy devices are an emerging segment at a significant rate and are estimated to show a noticeable growth during the forecast period. The therapy devices segment can further be classified as negative pressure wound therapy, ultrasound therapy, etc. Negative pressure wound therapy has gained much popularity in society. Furthermore, therapy devices provide a better recovery rate at an economical cost which can be easily affordable by economically low people. Additionally, technological advancement can provide optimal results, thereby encouraging the growth of this segment in the global diabetic foot ulcer treatment market.

Diabetic Foot Ulcer Treatment Market by End User

Based on end-user, the diabetic foot ulcer treatment market has been segmented into hospitals, clinics, ambulatory surgical centers, home care centers, and others. The hospital and clinics segment holds the largest revenue share in this market and is expected to show constant dominance in the forecast period. The dominance of the hospital segment is attributed to large patient footfall and the availability of enhanced technologies. Additionally, this segment has a high patient satisfaction rate. Also, it offers better reimbursement policies, thus, encouraging the growth of the market. While homecare centers, clinics, and ambulatory centers are expected to depict continuous development in the forecast period.

Diabetic Foot Ulcer Treatment Market by Region

Geographically, the global diabetic foot ulcer treatment market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global diabetic foot ulcer treatment market with the largest revenue share. The rapid adoption of enhanced technologies, availability of developed healthcare infrastructure with significant healthcare expenditure, and large base of international market players contributes to the dominance of the diabetic foot ulcer treatment market in this region. Additionally, growing cases of diabetic foot ulcers because of increasing practice of sedentary lifestyle, physical inactivity, and a high population base for obese people, is fueling the development of the market.

Asia Pacific is also considered the fastest growing region in this market. This growth can be attributed to the rapid adoption of the latest technologies, development in the healthcare infrastructure, improving medical tourism, and increasing prevalence of diabetes mellitus.

Competitive Landscape

Some of the prominent players operating in the global diabetic foot ulcer treatment market are:

Acelity L.P.Inc.
Integra LifeSciences Corporation
B. Braun Melsungen AG
ConvaTec Group Plc.
3M Healthcare
Cardinal Health Inc.
Smith & Nephew Plc.
Tissue Regenix Group Plc.
Mölnlycke Health Care AB
Coloplast Corp.
Medline Industries Inc.
Medtronic Plc.

Strategic Developments

In March 2022, research scientists from The University of Texas at Arlington developed a footwear technology to relieve high pressure on the feet during physical activities. This project also received a patent from a U.S. patent and trademark for a dual-layer insole for foot lesion prevention.
In June 2022, Orpyx Medical Technologies Inc. launched Orpyx SI Flex Sensory Insole system, which is a wearable device to prevent foot complications with peripheral neuropathy caused due to diabetes mellitus.

Report Scope

Report Attribute	Details
Market size value in 2021	US$ 3.54 billion
Revenue forecast in 2030	US$ 5.83 billion
Growth Rate	CAGR of 5.7% from 2022 to 2030
Base year for estimation	2021
Forecast period	2022-2030
Segments covered	By Type, Treatment Type, End-User, and Region.
Regional scope	North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Frequently Asked Questions About This Report

The growth of the diabetic foot ulcer treatment market is attributed to growing urbanization, increasing prevalence of diabetic foot ulcers, technological advancements in treatment techniques, and many more.

The Asia Pacific is estimated to experience rapid growth in the market during the projected period.

The diabetic foot ulcer treatment market is expected to grow at a CAGR of 5.7% in the forecast period from 2022 to 2030.

Top market players in diabetic foot ulcer treatment are Acelity L.P.Inc., Integra LifeSciences Corporation, B. Braun Melsungen AG, ConvaTec Group Plc., 3M Healthcare, Cardinal Health Inc., Smith & Nephew Plc., Tissue Regenix Group Plc., Mölnlycke Health Care AB, Coloplast Corp., Medline Industries Inc., and Medtronic Plc. among others.

Table of Content

INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
  1. Historical Years – 2020
  2. Base Year – 2021
  3. Forecasted Years – 2022 to 2030
3. Currency Used in the Report
RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
  1. Secondary Sources
  2. Primary Sources
4. Market Estimation Approach
  1. Bottom Up
  2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET- ANALYSIS & FORECAST, BY TYPE
1. Ischemic Ulcers
2. Neuro-Ischemic Ulcers
3. Neuropathic Ulcers
GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET- ANALYSIS & FORECAST, BY TREATMENT TYPE
1. Active Therapies
2. Wound Care Dressings
3. Therapy Devices
4. Others (Photodynamic Therapy, Photo Biomodulation, etc.)
GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET- ANALYSIS & FORECAST, BY END-USERS
1. Hospitals
2. Clinics
3. Ambulatory Surgical Centers
4. Home Care
GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET- ANALYSIS & FORECAST, BY REGION
1. North America Diabetic Foot Ulcer Treatment Market
  1. North America Diabetic Foot Ulcer Treatment Market, by Type
  2. North America Diabetic Foot Ulcer Treatment Market, by Treatment Type
  3. North America Diabetic Foot Ulcer Treatment Market, by End-Users
  4. North America Diabetic Foot Ulcer Treatment Market, by Country
    1. U.S.
      1. U.S. Diabetic Foot Ulcer Treatment Market, by Type
      2. U.S. Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. U.S. Diabetic Foot Ulcer Treatment Market, by End-Users
    2. Canada
      1. Canada Diabetic Foot Ulcer Treatment Market, by Type
      2. Canada Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Canada Diabetic Foot Ulcer Treatment Market, by End-Users
2. Europe Diabetic Foot Ulcer Treatment Market
  1. Europe Diabetic Foot Ulcer Treatment Market, by Type
  2. Europe Diabetic Foot Ulcer Treatment Market, by Treatment Type
  3. Europe Diabetic Foot Ulcer Treatment Market, by End-Users
  4. Europe Diabetic Foot Ulcer Treatment Market, by Country/Region
    1. Germany
      1. Germany Diabetic Foot Ulcer Treatment Market, by Type
      2. Germany Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Germany Diabetic Foot Ulcer Treatment Market, by End-Users
    2. U.K
      1. U.K Diabetic Foot Ulcer Treatment Market, by Type
      2. U.K Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. U.K Diabetic Foot Ulcer Treatment Market, by End-Users
    3. France
      1. France Diabetic Foot Ulcer Treatment Market, by Type
      2. France Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. France Diabetic Foot Ulcer Treatment Market, by End-Users
    4. Spain
      1. Spain Diabetic Foot Ulcer Treatment Market, by Type
      2. Spain Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Spain Diabetic Foot Ulcer Treatment Market, by End-Users
    5. Italy
      1. Italy Diabetic Foot Ulcer Treatment Market, by Type
      2. Italy Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Italy Diabetic Foot Ulcer Treatment Market, by End-Users
    6. Rest of Europe
      1. Rest of Europe Diabetic Foot Ulcer Treatment Market, by Type
      2. Rest of Europe Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Rest of Europe Diabetic Foot Ulcer Treatment Market, by End-Users
3. Asia Pacific Diabetic Foot Ulcer Treatment Market
  1. Asia Pacific Diabetic Foot Ulcer Treatment Market, by Type
  2. Asia Pacific Diabetic Foot Ulcer Treatment Market, by Treatment Type
  3. Asia Pacific Diabetic Foot Ulcer Treatment Market, by End-Users
  4. Asia Pacific Diabetic Foot Ulcer Treatment Market, by Country/Region
    1. China
      1. China Diabetic Foot Ulcer Treatment Market, by Type
      2. China Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. China Diabetic Foot Ulcer Treatment Market, by End-Users
    2. Japan
      1. Japan Diabetic Foot Ulcer Treatment Market, by Type
      2. Japan Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Japan Diabetic Foot Ulcer Treatment Market, by End-Users
    3. India
      1. India Diabetic Foot Ulcer Treatment Market, by Type
      2. India Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. India Diabetic Foot Ulcer Treatment Market, by End-Users
    4. South Korea
      1. South Korea Diabetic Foot Ulcer Treatment Market, by Type
      2. South Korea Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. South Korea Diabetic Foot Ulcer Treatment Market, by End-Users
    5. Australia
      1. Australia Diabetic Foot Ulcer Treatment Market, by Type
      2. Australia Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Australia Diabetic Foot Ulcer Treatment Market, by End-Users
    6. Rest of Asia Pacific
      1. Rest of Asia Pacific Diabetic Foot Ulcer Treatment Market, by Type
      2. Rest of Asia Pacific Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Rest of Asia Pacific Diabetic Foot Ulcer Treatment Market, by End-Users
4. Rest of the World Diabetic Foot Ulcer Treatment Market
  1. Rest of the World Diabetic Foot Ulcer Treatment Market, by Type
  2. Rest of the World Diabetic Foot Ulcer Treatment Market, by Treatment Type
  3. Rest of the World Diabetic Foot Ulcer Treatment Market, by End-Users
  4. Rest of the World Diabetic Foot Ulcer Treatment Market, by Region
    1. Latin America
      1. Latin America Diabetic Foot Ulcer Treatment Market, by Type
      2. Latin America Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Latin America Diabetic Foot Ulcer Treatment Market, by End-Users
    2. Middle East & Africa
      1. Middle America & Africa Diabetic Foot Ulcer Treatment Market, by Type
      2. Middle America & Africa Diabetic Foot Ulcer Treatment Market, by Treatment Type
      3. Middle America & Africa Diabetic Foot Ulcer Treatment Market, by End-Users
COMPANY PROFILES
1. Acelity L.P.Inc.
  1. Business Snapshot
  2. Product Offered
  3. Financial Details
  4. Strategic Development
2. Integra LifeSciences Corporation
3. B. Braun Melsungen AG
4. ConvaTec Group Plc.
5. 3M Healthcare
6. Cardinal Health Inc.
7. Smith & Nephew Plc.
8. Tissue Regenix Group Plc.
9. Mölnlycke Health Care AB
10. Coloplast Corp.
11. Medline Industries Inc.
12. Medtronic Plc.

*Insights on financial performance is subject to availability of information in public domain

Single User License

Multi User License

Enterprise User License

$4,750.00

Growth+Reports can now be customized as per client’s needs through GRG Health’s primary research and knowledge services capabilities

GRG Health’s unique GrowthMIX approach and robust research methodology helps us deliver unique & meaningful insights to our clients and uncover trends that won’t meet the standard approach

Ask For Customization Check Discount Inquire Before Buying

Snehal Deshmukh

Principle Consultant

Speak to analyst